The new EU Medical Device Regulation (EU Regulation 2017/745 - EU Medical Device Regulation) came into force on 25 May 2017. The transition period is scheduled to end on May 26, 2020 - now discussions are underway to extend this transition period by another...
Improvement of the GMP processes and upkeep of the production license at the new location - renewing the operating approval by the cantonal pharmacist.
In a time of crisis like this, the first commandment is to protect employees, customers and people in general. For this reason, gempex has closely monitored the development of COVID-19 infections from the very beginning and has acted in advance.
gempex Switzerland supports all aspects of cannabis medicines - cultivation, processing and operating licensing. Full-service in terms of Good Manufacturing Practices.
Expert presentation with Jobst Willers Engineering at pharmaDavos | Topic: GMP requirements, planning, construction and qualification of pharmaceutical laboratories and producing pharmacies
This Internet presence uses cookies. I consent to the use of cookies. For further information and the possibility to raise an objection, please click on ourPrivacy Policy.
